The Ethics of informed consent in novel treatment including a gender perspective

Main pillar: 

  • Science with and for Society

Budget: 

3 800 000

Currency: 

Euro

Call deadline: 

Tue, 30 Aug 2016

Statut: 

  • Open

Description: 

Specific Challenge:

The exponential development of knowledge resulting from biomedical research challenges the ethics of informed consent. Patients, practitioners, researchers, health authorities and other stakeholders are confronted with the difficulty to reconcile their legal and administrative environment, biomedical ethics, Human Rights and the increasing global availability of new effective treatments. For some worldwide high mortality diseases, this includes an important gender dimension. In addition to the ethical and social aspects, the economic dimension and potential impact of this challenge on EU health budgets is very significant.

 

Expected Impact:

Taking into account the gender dimension, will increase the EU standards of clinical research ethics, in particular the quality of informed consent by developing practical guidelines supporting the work of clinicians while stimulating innovation and increase the use of effective new treatments.

 

http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/2249-swafs-17-2016.html

Call documents: